Serial Number
98377989
Owner
JAGUAR GENE THERAPY, LLCAttorney
J. Dickson Phillips IIIFirst Use Date
Jan 16, 2024
Filing Date
Jan 26, 2024
AMP Trademark
Serial Number: 98377989 • Registration: 7896266
Trademark Classes
Owner Contact Info
TWO CONWAY PARK, SUITE 300
LAKE FOREST, IL 60045
Entity Type: 16
2 Conway Park, 150 N. Field Dr. Ste 300
Lake Forest, IL 60045
Entity Type: 16
Legal Representation
Correspondence Address
J. Dickson Phillips III ROBINSON BRADSHAW & HINSON, P.A.
1450 RALEIGH RD, SUITE 100
CHAPEL HILL, NC 27517
United States
Trademark Details
Filing Date
January 26, 2024
Registration Date
August 19, 2025
First Use Anywhere
January 16, 2024
First Use in Commerce
January 16, 2024
Published for Opposition
March 18, 2025
Goods & Services
Biomanufacturing for others, namely, manufacturing of pharmaceuticals using biological organism in the manufacturing process; custom manufacture for others of products relating to biotechnology, namely, recombinant proteins for use in the biotechnology industries; custom manufacture for others of cell therapy products; custom manufacture for others of gene therapy products; custom manufacture of pharmaceuticals in accordance with specific standards GMP regulations
Contract development and manufacturing organization (CDMO) services, namely, pharmaceutical drug development services; consulting and advisory services in the field of analytical development and quality control testing of pharmaceutical, gene therapy, and cell therapy products; consulting and advisory services in the field of manufacturing process development for pharmaceutical, gene therapy and cell therapy products; consulting in the field of chemistry manufacturing and controls (CMC) activities; testing of pharmaceutical, gene therapy, and cell therapy products and materials; quality control testing of pharmaceutical products and materials, namely, biopharmaceutical products and materials in accordance with specifications or requirements of regulatory standards applicable in target countries; testing and validation services of biopharmaceutical products to assure compliance with global regulatory requirements, specifications, and industry standards for pharmaceutical, cell therapy and gene therapy methods of development; technical consulting for regulatory compliance in the field of chemistry manufacturing and controls (CMC)